Hinge Health, Inc. Class A (HNGE)
NYSE:HNGE
Want to see HNGE full AI Analyst Report?
HNGE Stock Chart & Stats
$43.32
-$1.41(-3.71%)
At close: 4:00 PM EDT
$43.32
-$1.41(-3.71%)
Day’s Range― - ―
52-Week Range$30.08 - $66.55
Previous Close$36.79
Volume525.07K
Average Volume (3M)1.75M
Market Cap
$4.86B
Enterprise Value$4.17B
Total Cash (Recent Filing)$317.31M
Total Debt (Recent Filing)$6.97M
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Aug 04, 2026EPS Estimate
0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.58
Shares Outstanding54,655,926
10 Day Avg. Volume1,825,455
30 Day Avg. Volume1,746,358
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)9.72
Price to Sales (P/S)6.26
P/FCF Ratio21.54
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue6.45
Enterprise Value/Gross Profit7.98
Enterprise Value/Ebitda-7.97
Forecast
1Y Price Target
$70.55Price Target Upside62.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
EPS Forecast (FY)2.5
Revenue Forecast (FY)$801.58M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue Growth & Upward GuidanceConsistent high-single/low-double digit revenue growth and successive guidance raises indicate durable demand from employers and health plans. Repeated beats and higher outlook suggest expanding client adoption and contract scale that support predictable top‑line growth over the next 2–6 months.
Strong Cash Generation & Balance Sheet FlexibilityMaterial improvement in operating and free cash flow provides the firm financial flexibility to invest, buy back shares, and withstand cyclical headwinds. Robust cash conversion reduces dependence on external financing and underpins durable funding for product rollouts and commercial expansion.
Expanding Product & Commercial FootprintRapid network expansion and distribution partnerships increase care continuity and barriers to entry. Broadening provider coverage and PBM/plan relationships deepens integration into employer benefits, supporting sustainable member acquisition and greater lifetime value across the MSK care continuum.
Bears Say
Earnings Quality & Profitability VolatilityA severe GAAP loss alongside strong cash flow raises questions about recurring profitability drivers and non‑cash or one‑time charges. This earnings volatility makes near‑term return on equity and sustainable net income harder to predict and complicates long‑term profitability planning.
Device Cost Pressure As Enso ScalesScaling a hardware component elevates manufacturing, fulfillment, and warranty costs that can persistently raise unit COGS. Even with care‑team efficiencies, recurring device-related expenses may compress gross margins and require ongoing optimization to preserve the business's attractive unit economics.
Limited Medicare Channel Participation (CMS ACCESS)Opting out of a major Medicare participation pathway limits access to older populations and slows diversification into fee‑for‑service or Medicare Advantage volumes. This strategic choice narrows addressable market expansion and may reduce long‑term revenue diversification opportunities.
Hinge Health, Inc. Class A News
HNGE FAQ
What was Hinge Health, Inc. Class A’s price range in the past 12 months?
Hinge Health, Inc. Class A lowest stock price was $30.08 and its highest was $66.55 in the past 12 months.
What is Hinge Health, Inc. Class A’s market cap?
Hinge Health, Inc. Class A’s market cap is $4.86B.
When is Hinge Health, Inc. Class A’s upcoming earnings report date?
Hinge Health, Inc. Class A’s upcoming earnings report date is Aug 04, 2026 which is in 54 days.
How were Hinge Health, Inc. Class A’s earnings last quarter?
Hinge Health, Inc. Class A released its earnings results on May 05, 2026. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.397 by $0.053.
Is Hinge Health, Inc. Class A overvalued?
According to Wall Street analysts Hinge Health, Inc. Class A’s price is currently Undervalued.
Does Hinge Health, Inc. Class A pay dividends?
Hinge Health, Inc. Class A does not currently pay dividends.
What is Hinge Health, Inc. Class A’s EPS estimate?
Hinge Health, Inc. Class A’s EPS estimate is 0.61.
How many shares outstanding does Hinge Health, Inc. Class A have?
Hinge Health, Inc. Class A has 54,655,926 shares outstanding.
What happened to Hinge Health, Inc. Class A’s price movement after its last earnings report?
Hinge Health, Inc. Class A reported an EPS of $0.45 in its last earnings report, beating expectations of $0.397. Following the earnings report the stock price went up 10.231%.
Which hedge fund is a major shareholder of Hinge Health, Inc. Class A?
Currently, no hedge funds are holding shares in HNGE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hinge Health, Inc. Class A Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$70.55 (62.85% Upside)
$70.55 (62.85% Upside)
Blogger Sentiment
Bullish
HNGE Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.2%
Last 30 Days ▲ 5.8%
Last 30 Days ▲ 5.8%
News Sentiment
Bullish
Bullish news 79%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Positive
20 days / 200 days
Momentum
65.21%
12-Months-Change
Fundamentals
Return on Equity
-167.01%
Trailing 12-Months
Asset Growth
2.28%
Trailing 12-Months
Company Description
Hinge Health, Inc. Class A
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
HNGE Company Deck
HNGE Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: a material revenue beat, double-digit growth in billings, substantial margin expansion, strong free cash flow, raised full-year guidance, rapid client uptake of the new migraine program following FDA clearance, and expanding commercial traction (including SMB and Hinge Select). Headwinds and risks include limited near-term revenue from migraine (meaningful benefit expected in 2027), concentration of new bookings in the back half of the year, continued device-related cost pressures as Enso distribution scales, and a deliberate decision to forgo the CMS ACCESS program. Overall, the positives (robust growth, margin expansion, guidance raise, product and commercial wins) substantially outweigh the near-term lowlights and risks.View all HNGE earnings summariesHNGE Stock 12 Month Forecast
Average Price Target
$70.55
▲(62.85% Upside)
Technical Analysis
Ownership Overview
8.54% Insiders
17.12% Mutual Funds
67.21% Other Institutional Investors
1.74% Public Companies and
Individual Investors